Rising Adoption of Aerosol Packaging Market to Fuel Revenue Growth Through 2027
Nasal sprays contain the calcitonin drug that is used for the treatment of osteoporosis. This drug poses an increased risk of cancer. Therefore it is suggested by the Health Canada Report that some alternative drug should be used for the treatment of bone disorders. Nasal sprays that contained calcitonin drug were already withdrawn from the Canadian market in 2013. This move is likely to affect the pharmaceutical segment of the global aerosol packaging market across the globe.
View full press release